Akzo Nobel N.V. financials
Akzo Nobel N.V.
Country: NL Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
724500XYIJUGXAA5QD70 Financial statements
(EUR, as reported — unscaled; 99 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Cost of sales | €6.11B | €6.37B |
| Gross profit | €4.05B | €4.34B |
| Operating profit (EBIT) | €1.16B | €917.0M |
| Net finance income / (cost) | -€199.0M | -€102.0M |
| Finance costs | €248.0M | €163.0M |
| Profit before tax | €998.0M | €838.0M |
| Income tax expense | €326.0M | €246.0M |
| Profit for the year | €671.0M | €592.0M |
| — attributable to owners | €635.0M | €542.0M |
| — attributable to NCI | €36.0M | €50.0M |
| Total comprehensive income | €430.0M | €636.0M |
| Per share | ||
| Basic EPS | €3.71 | €3.17 |
| Diluted EPS | €3.69 | €3.16 |
| Cash flow statement | ||
| Dividends paid | €382.0M | €385.0M |
| Proceeds from borrowings | €2.45B | €2.31B |
| Repayments of borrowings | €3.04B | €2.60B |
| Net change in cash | €375.0M | -€148.0M |
| Balance sheet | ||
| Total assets | €13.95B | €14.25B |
| Non-current assets | €7.89B | €8.41B |
| Property, plant & equipment | €2.04B | €2.12B |
| Right-of-use assets | €294.0M | €318.0M |
| Intangible assets & goodwill | €3.80B | €4.05B |
| Current assets | €6.06B | €5.84B |
| Inventories | €1.53B | €1.72B |
| Trade & other receivables | €2.40B | €2.50B |
| Cash & equivalents | €1.62B | €1.30B |
| Total equity | €4.82B | €4.82B |
| — attributable to owners | €4.66B | €4.57B |
| Non-controlling interests | €163.0M | €242.0M |
| Non-current liabilities | €4.92B | €4.70B |
| Long-term borrowings | €3.67B | €3.67B |
| Current liabilities | €4.21B | €4.73B |
| Short-term borrowings | €1.19B | €1.70B |
| Trade & other payables | €2.69B | €2.74B |
| Deferred tax liabilities | €487.0M | €491.0M |
| Derived metrics | ||
| Operating margin | 11.5% | 8.6% |
| Net margin | 6.6% | 5.5% |
| Return on equity | 13.9% | 12.3% |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense | €378.0M | €371.0M |
| Adjustments For Finance Income Cost | -€199.0M | -€102.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €9.0M | €0 |
| Adjustments For Income Tax Expense | €326.0M | €246.0M |
| Adjustments For Undistributed Profits of Associates | €33.0M | €23.0M |
| Basic Earnings Loss Per Share From Continuing Operations | €3.72 | €3.17 |
| Basic Earnings Loss Per Share From Discontinued Operations | €-0.01 | €0.00 |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €1.60B | €1.27B |
| Cash Flows From Used In Financing Activities Continuing Operations | -€981.0M | -€684.0M |
| Cash Flows From Used In Investing Activities Continuing Operations | €442.0M | -€132.0M |
| Cash Flows From Used In Operating Activities Continuing Operations | €915.0M | €673.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | -€2.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €12.0M | €66.0M |
| Comprehensive Income Attributable To Owners of Parent | €418.0M | €570.0M |
| Current Provisions | €186.0M | €173.0M |
| Current Tax Assets Current | €209.0M | €150.0M |
| Current Tax Liabilities Current | €139.0M | €120.0M |
| Deferred Tax Assets | €401.0M | €422.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | €3.70 | €3.16 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €-0.01 | €0.00 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €1.54 | €1.54 |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €17.0M | €14.0M |
| Dividends Recognised As Distributions To Owners Per Share | €0.44 | €0.44 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€43.0M | -€32.0M |
| Equity and Liabilities | €13.95B | €14.25B |
| Finance Income | €49.0M | €61.0M |
| Gains Losses On Cash Flow Hedges Before Tax | €15.0M | €0 |
| Gains Losses On Exchange Differences On Translation Before Tax | -€360.0M | €148.0M |
| General and Administrative Expense | €649.0M | €655.0M |
| Income Tax Relating To Components of Other Comprehensive Income | -€7.0M | €31.0M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €8.0M | -€31.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €268.0M | €291.0M |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | -€1.0M | -€5.0M |
| Increase Decrease In Working Capital | -€166.0M | €206.0M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€66.0M | -€4.0M |
| Increase Decrease Through Sharebased Payment Transactions | €24.0M | €23.0M |
| Interest Paid Classified As Operating Activities | €162.0M | €174.0M |
| Interest Received Classified As Investing Activities | €48.0M | €54.0M |
| Investments In Associates Accounted For Using Equity Method | €232.0M | €228.0M |
| Issue of Equity | €0 | €0 |
| Noncurrent Provisions For Employee Benefits | €300.0M | €381.0M |
| Operating Expense Excluding Cost of Sales | €2.88B | €3.42B |
| Other Adjustments To Reconcile Profit Loss | €19.0M | €46.0M |
| Other Comprehensive Income | -€241.0M | €44.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €13.0M | -€135.0M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €5.0M | -€104.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€344.0M | €148.0M |
| Other Gains Losses | €390.0M | -€6.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | €10.0M | €0 |
| Other Longterm Provisions | €466.0M | €160.0M |
| Other Noncurrent Financial Assets | €1.13B | €1.27B |
| Payments From Changes In Ownership Interests In Subsidiaries | €17.0M | €4.0M |
| Profit Loss From Continuing Operations | €672.0M | €592.0M |
| Profit Loss From Discontinued Operations | -€1.0M | €0 |
| Purchase of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €309.0M | €306.0M |
| Reclassification Adjustments On Cash Flow Hedges For Which Hedged Future Cash Flows Are No Longer Expected To Occur Net of Tax | €15.0M | €0 |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | -€113.0M | €0 |
| Research and Development Expense | €274.0M | €296.0M |
| Revenue From Contracts With Customers | €10.16B | €10.71B |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €33.0M | €23.0M |
| Shortterm Deposits Not Classified As Cash Equivalents | €302.0M | €165.0M |
Methodology
Every line item above is a fact tagged in Akzo Nobel N.V.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.